Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A powerful agonist for metal ion interference therapy: Multiple programs of cell death to amplify tumor metalloimmunotherapy. | Biomaterials | 2026 | 41365036 | PubTator, text mining | PubMed |
| Omeprazole-mediated nanodelivery of copper for synchronous remodeling of copper influx and efflux in cuproptotic glioblastoma therapy. | Acta Biomater | 2026 | 41344596 | PubTator, text mining | PubMed |
| Oxaliplatin resistance in pancreatic ductal adenocarcinoma is non‑significantly mediated by diminished drug uptake but is highly linked to a poor apoptotic response to the cytotoxic threat. | Oncol Rep | 2026 | 41268611 | PubTator, text mining | PubMed |
| Copper-induced duodenal injury: Unveiling the dual role of cuproptosis and ferroptosis via the FDX1/GPX4 axis. | J Nutr Biochem | 2026 | 41224149 | PubTator, text mining | PubMed |
| Novel Ce/Cu-modified black ceramics disrupted mitochondrial dysfunction and tricarboxylic acid cycle to induce cuproptosis in osteosarcoma cells. | Biomater Adv | 2026 | 41218466 | PubTator, text mining | PubMed |
| Copper in Human Health and Disease: Insights from Inherited Disorders. | Physiology (Bethesda) | 2026 | 41213165 | PubTator, text mining | PubMed |
| A metabolic perspective on cuproptosis. | Trends Endocrinol Metab | 2026 | 40681425 | PubTator, text mining | PubMed |
| HIPPs of all trades: insights from pathogens on the function of HMA proteins at plasmodesmata. | J Exp Bot | 2026 | 40433940 | PubTator, text mining | PubMed |
| GATOR1 complex controls cisplatin sensitivity. | Cell Death Dis | 2025 | 41469472 | PubTator, text mining | PubMed |
| TRIM14 Regulation of Copper Homeostasis and Cuproptosis: A New Strategy to Overcome Chemoresistance in Glioblastoma. | Biomedicines | 2025 | 41463095 | PubTator, text mining | PubMed |
| IDEDNIK syndrome: a newly recognized rare genetic disorder caused by AP1S1 and AP1B1 mutations. | Front Neurol | 2025 | 41404470 | PubTator, text mining | PubMed |
| Retropseudogene insertion generated through retrotransposition in the ATP7A gene results in premature stop codons and a case of Menkes disease. | Front Neurol | 2025 | 41393994 | PubTator, text mining | PubMed |
| Eriocitrin inhibits sodium iodate-induced cuproptosis and barrier function impairment in retinal pigment epithelium via SIRT7/YAP/ATP7A pathway. | J Transl Med | 2025 | 41361469 | PubTator, text mining | PubMed |
| Correction to: The MNK-SYNGAP1 axis in specific learning disorder: gene expression pattern and new perspectives. | Eur J Pediatr | 2025 | 41324753 | PubTator, text mining | PubMed |
| Novel ATP7A Splice-Site Variant Causing Distal Motor Neuropathy and Occipital Horn Syndrome: Two Siblings and Literature Review. | Genes (Basel) | 2025 | 41010022 | PubTator, text mining | PubMed |
| Integrative analysis of molecular mechanisms in prostate cancer via single-cell RNA sequencing and weighted gene co-expression network analysis. | Sci Rep | 2025 | 41006377 | PubTator, text mining | PubMed |
| Epigenetic modification of cuproptosis by non-coding RNAs in cancer drug resistance. | Mol Cancer | 2025 | 40999456 | PubTator, text mining | PubMed |
| Genome-Wide CRISPR/Cas9 Screening Identifies the COMMANDER Recycling Complex as a Key Player in EV Uptake. | J Extracell Vesicles | 2025 | 40985903 | PubTator, text mining | PubMed |
| Ultrasound-activated copper-based sonosensitizer for dual-amplified ROS-mediated tumor therapy and cuproptosis induction. | J Mater Chem B | 2025 | 40985310 | PubTator, text mining | PubMed |
| The Expanding Genetic Architecture of Arteriopathies: From Canonical TAAD Genes to Emerging Connective Tissue and Signaling Pathways. | Med Sci (Basel) | 2025 | 40981152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=5